drugset / Trial / NCT07244510
Efficacy and Safety of SCT650C in Participants With Moderate to Severe Hidradenitis Suppurativa
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to assess efficacy, safety, pharmacokinetics and immunogenicity of subcutaneous SCT650C in patients with Moderate to Severe Hidradenitis Suppurativa
Timeline
- Start
- 2025-12-16
- Primary completion
- 2027-03-12
- Completion
- 2028-02-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | SCT650C | Monoclonal antibody | — | Subcutaneous |